Omic insights into various ceftazidime-avibactam-resistant Klebsiella pneumoniae isolates from two southern Italian regions

Ceftazidime-avibactam (CZA) is one of the best therapeutic options available for infections caused by Klebsiella pneumoniae carbapenemase (KPC)-producing bacteria. However, sporadic reports of CZA-resistant strains have been rapidly increasing in patients. Herein, we provide detailed case reports of...

Descripción completa

Detalles Bibliográficos
Autores principales: Bongiorno, Dafne, Bivona, Dalida A., Cicino, Claudia, Trecarichi, Enrico M., Russo, Alessandro, Marascio, Nadia, Mezzatesta, Maria Lina, Musso, Nicolò, Privitera, Grete F., Quirino, Angela, Scarlata, Giuseppe G. M., Matera, Giovanni, Torti, Carlo, Stefani, Stefania
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cellular and Infection Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9851273/
https://www.ncbi.nlm.nih.gov/pubmed/36683697
http://dx.doi.org/10.3389/fcimb.2022.1010979

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9851273/
https://www.ncbi.nlm.nih.gov/pubmed/36683697
http://dx.doi.org/10.3389/fcimb.2022.1010979

Ejemplares similares